Fig. 3From: Prognostic implications of systemic immune-inflammation index in myocardial infarction patients with and without diabetes: insights from the NOAFCAMI-SH registryPrimary and secondary endpoints. Long-term all-cause mortality and CV mortality in the whole cohort (A, D), and in the diabetic (B, E), and nondiabetic (C, F) cohorts according to the tertiles of SII level, respectively. CV cardiovascularBack to article page